PHARM.AS Financials

Financials

Trends

* Timeframes marked with (Est.) are analyst estimates based on consensus data.

Details

Breakdown	2025	2024	Change %
Total Revenue	376.134.000	297.200.000	26.6%
Cost of Revenue	45.500.000	35.399.000	28.5%
Gross Profit	330.634.000	261.801.000	26.3%
	309.753.000	265.466.000	16.7%
Operating Income	20.881.000	-3.665.000	669.7%
Pretax Income	12.847.000	-8.492.000	251.3%
Net Income Common Stockholders	2.851.000	-11.841.000	124.1%
	--	--	--
	--	--	--